<DOC>
	<DOCNO>NCT00409201</DOCNO>
	<brief_summary>30 patient randomly select administer either reboxetine placebo . change cognition behavior assess computer test scale six week study period .</brief_summary>
	<brief_title>Reboxetine Adjuvant Therapy Treatment Schizophrenia</brief_title>
	<detailed_description>participant administer pan , sans , esr , calgary , progesterom , sexual functioning scale , ham-a , covy , hamilton depression scale , cgi cgi improve rating first visit , well blood test , ecg weight . test use computer cognitive test ( cogscan test ) last 45 minute . next , give either two week dose placebo treatment ( 2 mg * 2 daily first week , 4 mg. day , 2 mg. night second week ) . two week dose increase 4 mg. * 2 daily . four week test readministered , well six week . study conclude 6 week , follow readministration test . physical examination also administer conclusion .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>schizophrenia type 18 &gt; uti &gt; 65 non organic state depression treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>reboxetine</keyword>
	<keyword>cognitive</keyword>
	<keyword>behavior</keyword>
</DOC>